Cwm LLC Trimmed Its Myriad Genetics INC (MYGN) Holding by $5.81 Million

Erika Holt
January 13, 2018

The hedge fund held 125,000 shares of the health care company at the end of 2017Q3, valued at $6.80 million, up from 100,000 at the end of the previous reported quarter. Primecap Mgmt Ca invested 0.58% in Seattle Genetics, Inc. On the stock's most recent trading day, the company's shares ended the regular session at $53.38, which is 25.15% lower than its 52-week high. About 273,894 shares traded. They set an outperform rating and a $58.00 price target on the stock. (MD) by 18.02% based on its latest 2017Q3 regulatory filing with the SEC. Lagoda Investment Management Lp sold 91,835 shares as the company's stock rose 1.68% with the market. The biotechnology company reported ($0.19) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.42) by $0.23. The stock increased 0.53% or $0.34 during the last trading session, reaching $65.09. About 4,549 shares traded. It has outperformed by 36.12% the S&P500. The shares were sold at an average price of $55.40, for a total value of $1,043,292.80. The co's performance for 6 months was reduced of -0.67%, 1-year performance stands at -9.54% and year to date showing reduced performance of -0.22%.

The stock's 50-day average volume has been 895,326 shares, with an average of 75% of medium term indicators pointing toward Sell. 11 funds opened positions while 16 raised stakes. Schwab Charles Invest stated it has 0% of its portfolio in United States Lime & Minerals, Inc. Through this figure traders can analyze that SGEN show whether or not a stock now most active and standing in buying side or sell side. Granite Inv Prns Llc holds 13,114 shares or 0.07% of its portfolio. (NASDAQ:RGLS). Morgan Stanley owns 5,699 shares for 0% of their portfolio. (NASDAQ:RGLS) for 580,000 shares. Mufg Americas reported 160 shares. The stock of A. O. Smith Corporation (NYSE:AOS) earned "Buy" rating by BB&T Capital on Wednesday, September 23. (NASDAQ:MYGN). Virginia Retirement System Et Al reported 48,500 shares stake. State Street Corporation holds 0% in Regulus Therapeutics Inc. State Street has invested 0% in K12 Inc. Moreover, Technologies Crossover Mngmt Vii Limited has 2.73% invested in K12 Inc.

Investors sentiment decreased to 1.13 in Q3 2017. Its down 0.52, from 1.3 in 2017Q2. It is negative, as 33 investors sold MYGN shares while 72 reduced holdings. 30 funds opened positions while 30 raised stakes. Century Companies stated it has 9,816 shares or 0% of all its holdings. Tekla Mgmt Ltd Liability Corp invested in 223,700 shares or 0.44% of the stock.

Analysts await Seattle Genetics, Inc. (NASDAQ:SGEN). Eqis Cap accumulated 25,171 shares. Toronto Dominion Bankshares invested in 4,219 shares or 0% of the stock. Nomura Asset Management Limited has invested 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN) to report earnings on February, 8. Fjarde Ap invested in 26,874 shares. 4,196 were reported by Stifel Corp. (NASDAQ:SGEN). Strs Ohio holds 0% or 1,235 shares. (NASDAQ:SGEN). Tocqueville Asset Mngmt Limited Partnership has invested 0.02% in Seattle Genetics, Inc. Over the last five days, shares have faced -6.75% losses and now is down -10.34% since hitting its 200-day moving average of $54.78. Opus Point Ptnrs Management Ltd Llc accumulated 2.01% or 41,263 shares.

Turning to TAL Education Group (NYSE:TAL), its shares were trading at $32.4 a retreat of $-0.86, on the trading floor. Credit Suisse Ag, a Switzerland-based fund reported 250,677 shares.

I Am Alive And Well, El-Zakzaky Speaks Out
An official of the DSS, who preferred to remain anonymous, told newsmen that El-Zakzaky was hale and hearty. Members of the group recently clashed with the police when they sought to protest at the national assembly.

Nisa Investment Advisors LLC Has $16.42 Million Position in Danaher Co. (DHR)
The hedge funds in our partner's database now have: 511.08 million shares, up from 508.92 million shares in 2017Q2. The institutional investor acquired 6,968 shares of the conglomerate's stock, valued at approximately $647,000.

Chelsea Manning files to run for US Senate seat in Maryland
The Washington Post first reported Saturday that Manning has filed to run in Maryland for the seat of Democratic Sen. Ben Cardin , Maryland's senior congressperson, for the gathering assignment in November.

Since September 1, 2017, it had 0 buys, and 3 insider sales for $1.36 million activity. Over the last ninety days, insiders have sold 138,378 shares of company stock worth $8,121,108. (NASDAQ:SGEN) was sold by SIMPSON TODD E on Wednesday, September 6.

Additionally, according to the most recent 13F filing from Seattle Genetics, Inc.

Among 3 analysts covering Cutera (NASDAQ:CUTR), 3 have Buy rating, 0 Sell and 0 Hold.

In related news, insider Clay B. Siegall sold 18,832 shares of the company's stock in a transaction dated Friday, November 10th. Shares for $475,414 were sold by DRACHMAN JONATHAN G on Thursday, August 24. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. Therefore 20% are positive. Seattle Genetics has $7500 highest and $4300 lowest target. On Monday, June 26 the stock rating was maintained by Cowen & Co with "Hold". Cantor Fitzgerald set a $50.00 price target on Seattle Genetics and gave the company a "hold" rating in a report on Tuesday, December 12th. (NASDAQ:SGEN) on Thursday, July 27 with "Hold" rating. The firm has a market capitalization of $7,452.61, a PE ratio of -60.88 and a beta of 2.37. The firm has "Hold" rating by Oppenheimer given on Tuesday, October 10. The rating was initiated by Goldman Sachs with "Sell" on Wednesday, November 18. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. RBC Capital Markets maintained the stock with "Hold" rating in Tuesday, August 8 report. Needham maintained Seattle Genetics, Inc. (NASDAQ:SGEN) rating on Friday, October 27.

Among 2 analysts covering K12 (NYSE:LRN), 2 have Buy rating, 0 Sell and 0 Hold. (NYSE:LRN) rating on Wednesday, July 12.

Other reports by

Discuss This Article